GNCA.OQ

Chart for GNCA.OQ

About

Genocea Biosciences, Inc. is a United States-based clinical-stage company that develops T cell vaccines. The Company utilizes T cell immunity to develop the next generation of vaccines. It designs vaccines using ATLAS, its technology platform. It identifies T cell antigens to induce immune responses. Its pipeline of T cell... (more)

Overall

Beta: --
Market Cap (Mil.): 176.70
Shares Outstanding (Mil.): 17.41
Dividend: --
Yield (%): --

Financials

  GNCA.OQ Industry Sector
P/E (TTM): -- 33.02 33.86
EPS (TTM): -1.87 -- --
ROI: -72.37 18.15 17.39
ROE: -- 18.85 18.25
Search Stocks

Competitors

  Price Change
Novartis AG (NOVN.VX) CHF87.75 -0.50
Pfizer Inc. (PFE.N) $30.05 -0.13
Merck & Co., Inc. (MRK.N) $60.28 -0.30
Sanofi SA (SASY.PA) €87.41 -1.46
AstraZeneca plc (AZN.L) 4,414.00p -163.50
GlaxoSmithKline plc (GSK.L) 1,422.00p -21.50
Vical Incorporated (VICL.OQ) $1.19 +0.06

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks